Pfizer Saudi Limited signed an exclusive commercial agreement with Tabuk Pharmaceuticals. The deal will permit Pfizer to advertise and promote branded and high-value generic drugs, such as medicines that provide treatment for kidney dialysis, kidney transplant, urology, and the central nervous system. This agreement is part of a larger Vision 2030 effort to strengthen local manufacturing capabilities. Pfizer started production at a $50 million plant in Saudi Arabia in January.
Pfizer Signs Commercial Agreement
You also might be interested in
On June 20th, Edward Burton, President and CEO of the[...]
The American IT giant Oracle, which specializes in cloud computing[...]
The Saudi Industrial Development Fund (SIDF) announced a $1 billion stimulus package[...]